Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Downgrades OncoSec Medical to Neutral

BTIG Downgrades OncoSec Medical to Neutral

BTIG analyst Kaveri Pohlman downgrades OncoSec Medical (NASDAQ:ONCS) from Buy to Neutral.

byBenzinga Newsdesk

November 14, 2022

1 minute read

BTIG analyst Kaveri Pohlman downgrades OncoSec Medical (NASDAQ:ONCS) from Buy to Neutral.

$100 Invested In Pioneer Natural Resources 20 Years Ago Would Be Worth This Much Today

By Benzinga Insights

May 11, 10:00 AM

Pioneer Natural Resources (NYSE:PXD) has outperformed the market over the past 20 years by 3.57% on an annualized…

PXD

‘Roaring Kitty’ Comeback Makes Cat-Themed Coins Explode: ROAR Shoots Up Over 500%

By Aniket Verma

May 14, 1:56 AM

The "Roaring Kitty" mania rippled across the meme coin market, causing coins themed on kitty avatars to soar to unprecedented heights.

$DOGE

Las Vegas-Based Planet 13 Expands Retail Portfolio Into Illinois With Waukegan Dispensary

By Joana Scopel

December 8, 4:11 PM

Las Vegas-based Planet 13 Holdings Inc. (OTC: PLNHF) recently inaugurated a new cannabis shop in Waukegan, Illinois, marking a strategic expansion in its retail portfolio.

PLNHF

Barclays Maintains Underweight on Antero Midstream, Raises Price Target to $10

By Benzinga Newsdesk

October 19, 7:18 AM

Barclays analyst Marc Solecitto maintains Antero Midstream (NYSE:AM) with a Underweight and raises the price target from $9 to $10.

BTIG Downgrades OncoSec Medical to Neutral

Related Posts

$100 Invested In Pioneer Natural Resources 20 Years Ago Would Be Worth This Much Today

‘Roaring Kitty’ Comeback Makes Cat-Themed Coins Explode: ROAR Shoots Up Over 500%

Las Vegas-Based Planet 13 Expands Retail Portfolio Into Illinois With Waukegan Dispensary

Barclays Maintains Underweight on Antero Midstream, Raises Price Target to $10